1. Dipòsit Digital de la Universitat de Barcelona
  2. Recerca
  3. Institut d'lnvestigació Biomèdica de Bellvitge (IDIBELL)
  4. Articles publicats en revistes (Institut d'lnvestigació Biomèdica de Bellvitge (IDIBELL))
Please use this identifier to cite or link to this item: https://hdl.handle.net/2445/126488
Full metadata record
DC FieldValueLanguage
dc.contributor.authorImaz, Arkaitz-
dc.contributor.authorLlibre, Josep María-
dc.contributor.authorNavarro Bernabé, Joan-
dc.contributor.authorCurto, J. J. (Jorge Juan)-
dc.contributor.authorClotet, Bonaventura, 1953--
dc.contributor.authorCrespo, M.-
dc.contributor.authorMurillo Rubio, Óscar-
dc.contributor.authorFerrer, Elena-
dc.contributor.authorSaumoy, Maria-
dc.contributor.authorTiraboschi, Juan Manuel-
dc.contributor.authorPodzamczer Palter, Daniel-
dc.date.accessioned2018-11-27T11:38:22Z-
dc.date.available2018-11-27T11:38:22Z-
dc.date.issued2012-11-11-
dc.identifier.urihttps://hdl.handle.net/2445/126488-
dc.description.abstractPurpose of the study: few clinical trials have compared non-nucleoside reverse transcriptase inhibitors (NNRTI) and ritonavir-boosted protease inhibitors (PI/r) as initial combined antiretroviral therapy (cART) for HIV-1-infected patients with high plasma viral load (pVL), and non-conclusive results have been reported. We compared the effectiveness between NNRTI and PI/r as first-line cART fof HIV-1-infected patients with high pVL.-
dc.format.extent1 p.-
dc.format.mimetypeapplication/pdf-
dc.language.isoeng-
dc.publisherWiley-
dc.relation.isformatofReproducció del document publicat a: https://doi.org/10.7448/IAS.15.6.18235-
dc.relation.ispartofJournal of the International Aids Society, 2012, vol. 15, num. 18235, p. 147-
dc.relation.urihttps://doi.org/10.7448/IAS.15.6.18235-
dc.rightscc by (c) Imaz et al., 2012-
dc.rights.urihttp://creativecommons.org/licenses/by/3.0/es/*
dc.sourceArticles publicats en revistes (Institut d'lnvestigació Biomèdica de Bellvitge (IDIBELL))-
dc.subject.classificationInfeccions per VIH-
dc.subject.classificationAntiretrovirals-
dc.subject.otherHIV infections-
dc.subject.otherAntiretroviral agents-
dc.titleEffectiveness of first-line antiretroviral therapy based on NNRTIs vs ritonavir-boosted PIs in HIV-1 infected patients with high plasma viral load-
dc.typeinfo:eu-repo/semantics/article-
dc.typeinfo:eu-repo/semantics/publishedVersion-
dc.date.updated2018-07-24T12:52:22Z-
dc.rights.accessRightsinfo:eu-repo/semantics/openAccess-
Appears in Collections:Articles publicats en revistes (Institut d'lnvestigació Biomèdica de Bellvitge (IDIBELL))

Files in This Item:
File Description SizeFormat 
ImazA.pdf178.06 kBAdobe PDFView/Open
Show simple item record


This item is licensed under a Creative Commons License Creative Commons